Advancing Rapid Sepsis Detection

Building a better tomorrow

About Us

Diagnostic Ventures is proud to work with leading PhD researchers at Brigham Young University. Our rapid sepsis diagnostic technology has been in development since 2016 and can currently detect the 5 most deadly sepsis pathogens in as little as 1 hour without a blood culture.

Originally funded by a $5.2M grant from the National Institute of Health, testing is being expanded to cover 30+ sepsis-causing pathogens and resistance genes.

This product is under development and not approved for sale. This product is not yet FDA approved.


Our breakthrough sepsis test

Step 1

Blood with bacteria is placed into the disk

services image

Step 2

Spin the blood

services image

Step 3

Separate pathogens from interferents via sedimentary forces

services image

Step 4

Slow at a precise rate to separate plasma from the interferents and prevent remixing

services image
1. Zanotti-Cavazzoni S. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.  Yearbook of Critical Care Medicine. 2007; 2007:187-188. doi:10.1016/s0734-3299(08)70339-3.